Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease.
To obtain low and high parasite loads in the acute phase of Chagas' disease, A/J mice were infected with 10(3) or 10(5) Trypanosoma cruzi trypomastigotes of the Y strain and treated on day 6 with benznidazol. One year later, chronically infected mice were screened for subpatent parasitemias, tissue pathology, and immune response. Mice infected with the high parasite inoculum showed higher levels of chronic parasitemias, heart and striated muscle inflammation, and activation of the immune system than did mice infected with the low inoculum. Concerning the activation of the immune system, the main findings for high-dose-infected mice were (i) increased numbers of splenocytes, with preferential expansion of CD8(+) and B220(-) CD5(-) cells, many of them bearing a macrophage phenotype; (ii) higher frequencies of B (B220(+)), CD4(+), and CD8(+) large lymphocytes; (iii) a shift of CD4(+) cells towards a CD45RBLow phenotype; (iv) increased frequencies of both CD45RBLow and CD45RBHigh large CD4(+) cells; (v) augmented numbers of total immunoglobulin (Ig)-secreting cells, with predominance of IgG2a-producing cells; and (vi) increased production of gamma interferon and interleukin 4. In addition, these mice presented lower IgM and higher IgG2a and IgG1 parasite-specific serum antibody levels. Our results indicate that the parasite load at the acute phase of T. cruzi infection influences the activation of the immune system and development of Chagas' disease pathology at the late chronic phase of the disease.
Marinho
C R
CR
Department of Immunology, Instituto de Ciências Biomédicas, Universidade de São Paulo, Brazil.
D'Império Lima
M R
MR
Grisotto
M G
MG
Alvarez
J M
JM
D000208:Acute Disease; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000921:Antibody-Producing Cells / Q000473:pathology; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D014355:Chagas Disease / Q000276:immunology* / Q000469:parasitology / Q000473:pathology*; D002908:Chronic Disease; D016207:Cytokines / Q000378:metabolism; D005260:Female; D007107:Immune System / Q000469:parasitology* / Q000473:pathology; D007274:Injections, Intraperitoneal; D017493:Leukocyte Common Antigens / Q000096:biosynthesis; D016131:Lymphocyte Subsets / Q000276:immunology / Q000473:pathology; D051379:Mice; D008805:Mice, Inbred A; D018482:Muscle, Skeletal / Q000469:parasitology / Q000473:pathology; D009205:Myocarditis / Q000469:parasitology / Q000473:pathology; D009220:Myositis / Q000469:parasitology / Q000473:pathology; D018512:Parasitemia / Q000276:immunology* / Q000469:parasitology / Q000473:pathology*; D013154:Spleen / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D014349:Trypanosoma cruzi / Q000276:immunology*
D000913:Antibodies, Protozoan; D016207:Cytokines; D017493:Leukocyte Common Antigens